References
- Mauch PM, Kalish LA, Kadin M, Coleman CN, Osteen R, Hellman S. Patterns of presentation of Hodgkin disease. Implications for etiology and pathogenesis. Cancer 1993;71:2062–2071.
- Cervantes F, Briones J, Bruguera M, et al Hodgkin's disease presenting as a cholestatic febrile illness: incidence and main characteristics in a series of 421 patients. Ann Hematol 1996;72:357–360.
- Rowbotham D, Wendon J, Williams R. Acute liver failure secondary to hepatic infiltration: a single centre experience of 18 cases. Gut 1998;42:576–580.
- Abdulkader I, Fraga M, Gonzalez-Quintela A, et al Prolonged survival after liver transplantation for Hodgkin's disease-induced fulminant liver failure. Hepatogastroenterology 2005;52:217–219.
- Kosmidou IS, Aggarwal A, Ross JJ, Worthington MG. Hodgkin's disease with fulminant non-alcoholic steatohepatitis. Dig Liver Dis 2004;36:691–693.
- Dourakis SP, Tzemanakis E, Deutsch M, Kafiri G, Hadziyannis SJ. Fulminant hepatic failure as a presenting paraneoplastic manifestation of Hodgkin's disease. Eur J Gastroenterol Hepatol 1999;11:1055–1058.
- Woolf KMW, Wei MC, Link MP, Arber DA, Warnke RA. Nodular lymphocyte-predominant Hodgkin lymphoma presenting as fulminant hepatic failure in a pediatric patient: a case report with pathologic, immunophenotypic, and molecular findings. Appl Immunohistochem Mol Morphol 2008;16:196–201.
- Vardareli E, Dündar E, Aslan V, Gülbaş Z. Acute liver failure due to Hodgkin's lymphoma. Med Princ Pract 2004;13:372–374.
- Olnes M, Alli P, Freedman A, Auster M, Erlich R. Hematologic malignancies with extramedullary spread of disease. Case 3. Extra-nodal Hodgkin's disease present as rapidly progressive liver failure. J Clin Oncol 2003;21:1890–1891.
- Trewby PN, Portman B, Brinkley DM, Williams R. Liver disease as presenting manifestation of Hodgkin's disease. Q J Med 1979;48:137–150.
- Lefkowitch JH, Flakow S, Whitlock RT. Hepatic Hodgkin's disease simulating cholestatic hepatitis with liver failure. Arch Pathol Lab Med 1985;109:424–426.
- McCarthy J, Gopal AK. Successful use of full-dose dexamethasone, high-dose cytarabine, and cisplatin as part of initial therapy in non-Hodgkin and Hodgkin lymphoma with severe hepatic dysfunction. Clin Lymphoma Myeloma 2009;9:167–170.
- Ballonoff A, Kavanagh B, Nash R, et al Hodgkin lymphoma-related vanishing bile duct syndrome and idiopathic cholestasis: statistical analysis of all published cases and literature review. Acta Oncol 2008;47:962–970.
- Maeda LS, Advani RH. The emerging role for rituximab in the treatment of nodular lymphocyte predominant Hodgkin lymphoma. Curr Opin Oncol 2009;21:397–400.
- Altintas A, Cil T, Pasa S, et al Clinical significance of elevated antinuclear antibody test in patients with Hodgkin's and Non Hodgkin's lymphoma: a single center experience. Minerva Med 2008;99:7–14.